Nothing Special   »   [go: up one dir, main page]

GR3019522T3 - Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material - Google Patents

Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material

Info

Publication number
GR3019522T3
GR3019522T3 GR960400911T GR960400911T GR3019522T3 GR 3019522 T3 GR3019522 T3 GR 3019522T3 GR 960400911 T GR960400911 T GR 960400911T GR 960400911 T GR960400911 T GR 960400911T GR 3019522 T3 GR3019522 T3 GR 3019522T3
Authority
GR
Greece
Prior art keywords
depot
pct
retard
materials
systems
Prior art date
Application number
GR960400911T
Other languages
English (en)
Inventor
Wolfgang Ritter
Rudolf Lehmann
Rainer Sorg
Original Assignee
Henkel Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Kgaa filed Critical Henkel Kgaa
Publication of GR3019522T3 publication Critical patent/GR3019522T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31786—Of polyester [e.g., alkyd, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR960400911T 1991-04-17 1996-04-02 Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material GR3019522T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4112464A DE4112464A1 (de) 1991-04-17 1991-04-17 Verbesserte retard-systeme fuer die zeitverzoegerte freigabe medizinischer und/oder biologischer wertstoffe aus einem depot-traegermaterial
PCT/EP1992/000825 WO1992018108A1 (de) 1991-04-17 1992-04-11 Verbesserte retard-systeme für die zeitverzögerte freigabe medizinischer und/oder biologischer wertstoffe aus einem depot-trägermaterial

Publications (1)

Publication Number Publication Date
GR3019522T3 true GR3019522T3 (en) 1996-07-31

Family

ID=6429738

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960400911T GR3019522T3 (en) 1991-04-17 1996-04-02 Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material

Country Status (14)

Country Link
US (1) US5538738A (el)
EP (1) EP0580689B1 (el)
JP (1) JP3351523B2 (el)
AT (1) ATE133857T1 (el)
AU (1) AU661303B2 (el)
BR (1) BR9205903A (el)
CA (1) CA2108680A1 (el)
DE (2) DE4112464A1 (el)
DK (1) DK0580689T3 (el)
ES (1) ES2083167T3 (el)
FI (1) FI934569A0 (el)
GR (1) GR3019522T3 (el)
NO (1) NO933345L (el)
WO (1) WO1992018108A1 (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19646782C2 (de) * 1996-11-13 2000-05-25 Merck Patent Gmbh Bioresorbierbare Polymerisationsprodukte aus strahlungshärtbaren Bindemittelsystemen
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
GB0007419D0 (en) † 2000-03-27 2000-05-17 Smithkline Beecham Gmbh Composition
CZ294328B6 (cs) * 2002-08-22 2004-11-10 Pliva-Lachema A. S. Biodegradabilní kompozice s prolongovaným uvolňováním biologicky aktivní látky a způsob její výroby
EP1605863B1 (en) 2003-03-14 2016-09-07 Intersect ENT, Inc. Sinus delivery of sustained release therapeutics
MX2007012324A (es) 2005-04-04 2008-02-12 Sinexus Inc Dispositivo y metodo para tratar condiciones del seno paranasal.
JP2009501722A (ja) * 2005-07-15 2009-01-22 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト ドロスピレノン含有経皮用薬剤供給装置及びその供給方法
US8535707B2 (en) 2006-07-10 2013-09-17 Intersect Ent, Inc. Devices and methods for delivering active agents to the osteomeatal complex
AU2008338586B2 (en) 2007-12-18 2015-01-29 Intersect Ent, Inc. Self-expanding devices and methods therefor
CA2732355A1 (en) 2008-08-01 2010-02-04 Intersect Ent, Inc. Methods and devices for crimping self-expanding devices
EP2370060B1 (en) 2008-11-27 2017-05-03 B.R.A.I.N. Biotechnology Research and Information Network AG Hydrophobins as surface active proteins as excipients in solid pharmaceutical formulations
EP2429624B1 (en) 2009-05-15 2014-04-02 Intersect ENT, Inc. A combination of an expandable device and a delivery device.
AU2014236729B2 (en) 2013-03-14 2018-11-22 Intersect Ent, Inc. Systems, devices, and method for treating a sinus condition
TWI503625B (zh) 2013-08-23 2015-10-11 Ind Tech Res Inst 感光性組成物與光阻
CA2974376A1 (en) 2015-01-22 2016-07-28 Intersect Ent, Inc. Drug-coated balloon

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2807132C2 (de) * 1978-02-20 1983-11-03 Battelle-Institut E.V., 6000 Frankfurt Implantierbares Pharmaka-Depot
EP0085944B1 (de) * 1982-02-10 1986-04-09 Henkel Kommanditgesellschaft auf Aktien Chirurgische Bindemittelsysteme zum Verkleben von körpereigenem Hartgewebe gewünschtenfalls mit Kunststoff und/oder Metall
DE3204504A1 (de) * 1982-02-10 1983-08-18 Henkel KGaA, 4000 Düsseldorf Neue schwerfluechtige mono- und/oder bis-(meth)-acrylate und ihre verwendung
DE3716302C2 (de) * 1987-05-15 1996-02-01 Henkel Kgaa Verbesserte resorbierbare Knochenwachse und ihre Verwendung
DE3825211A1 (de) * 1988-07-25 1990-02-01 Henkel Kgaa Verbesserte koerperresorbierbare knochenwachse (iii)
DE3939161A1 (de) * 1989-11-27 1991-05-29 Henkel Kgaa Verbesserte reaktivsysteme und/oder polymermassen fuer den gewebekontakt mit dem lebenden koerper

Also Published As

Publication number Publication date
FI934569A (fi) 1993-10-15
BR9205903A (pt) 1994-07-05
WO1992018108A1 (de) 1992-10-29
DE59205311D1 (de) 1996-03-21
ATE133857T1 (de) 1996-02-15
JPH06506672A (ja) 1994-07-28
JP3351523B2 (ja) 2002-11-25
AU661303B2 (en) 1995-07-20
DK0580689T3 (da) 1996-06-17
EP0580689A1 (de) 1994-02-02
US5538738A (en) 1996-07-23
EP0580689B1 (de) 1996-02-07
NO933345D0 (no) 1993-09-20
ES2083167T3 (es) 1996-04-01
NO933345L (no) 1993-09-20
AU1576092A (en) 1992-11-17
DE4112464A1 (de) 1992-10-22
CA2108680A1 (en) 1992-10-18
FI934569A0 (fi) 1993-10-15

Similar Documents

Publication Publication Date Title
GR3019522T3 (en) Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material
DK88385A (da) Biologisk nedbrydeligt polypeptid samt anvendelse deraf til gradvis frigivelse af laegemidler
FI953442A (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
NZ236002A (en) Transdermal delivery system for 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
AU4718496A (en) Use of aerogels in agriculture
GEP20043375B (en) APRIL-Receptor (BCMA) and Use Thereof
DE69612373D1 (de) Arzneimittelhaltiges tierfutter
ATE192338T1 (de) Pharmazeutisches präparat zur synergistischen aktivierung natürlicher killerzellen
DE69213739D1 (de) Osteogene proteine enthaltende arzneimittel
HUT73197A (en) Polymer compositions, storage compositions, processes for producing thereof and articles produced therefrom
BG101278A (en) Hard systems designed for controlled release of moleculesintroduced in them and methods for their preparation
MX9805191A (es) Sistema, metodo y dispositivo para liberar de manera controlada un producto.
DK0609280T3 (da) Humane IL-3 varianter
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
DE68914274D1 (de) Quellfähiger Verbundstoff, geeigenete Substrate zu seiner Herstellung und seine Anwendungen.
DE69623652D1 (de) Formulierung zur peptidfreisetzung
ATE499069T1 (de) Flüssige polymerlosung zur kontrollierten freisetzung von bioaktiven substanzen
MX9709606A (es) Sistema liquido de liberacion controlada y de viscosidad elevada.